NCT01411293

Brief Summary

The purpose of this study is to define whether the acute consumption of low-fat milk protects against postprandial vascular endothelial dysfunction by reducing oxidative stress responses that limit nitric oxide bioavailability to the vascular endothelium. The investigators hypothesis is that the consumption of low-fat milk will improve postprandial vascular endothelial function in an oxidative stress-dependent manner that allows greater nitric oxide (NO) bioavailability. The objectives of this study are to 1) examine improvements in postprandial vascular endothelial function in response to low-fat milk ingestion, 2) define low-fat milk-mediated improvements in circulating biomarkers of redox status, and 3) define the mechanism by which low-fat milk improves NO bioavailability. Collectively, the successful completion of these studies is expected to define NO mediated activities of low-fat milk that protect against vascular endothelial dysfunction in individuals at high risk for developing CVD.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
21

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Aug 2011

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 1, 2011

Completed
3 days until next milestone

First Submitted

Initial submission to the registry

August 4, 2011

Completed
4 days until next milestone

First Posted

Study publicly available on registry

August 8, 2011

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2012

Completed
1.2 years until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2013

Completed
Last Updated

January 6, 2014

Status Verified

January 1, 2014

Enrollment Period

1 year

First QC Date

August 4, 2011

Last Update Submit

January 3, 2014

Conditions

Keywords

cardiovascular diseaseoxidative stressdairy consumptionmetabolic syndromeobesityendothelial function

Outcome Measures

Primary Outcomes (1)

  • endothelial function

    Brachial artery flow-mediated dilation will be assessed at 30 min intervals during a 3 hour postprandial period

    3 hours

Secondary Outcomes (1)

  • Biomarkers of oxidative stress and nitric oxide metabolism

    3 hours

Study Arms (2)

Low-Fat Dairy

EXPERIMENTAL

Participants will ingest 2 cups of low-fat milk on 1 occasion prior to measure postprandial changes in vascular function

Other: Low-Fat Milk

Rice Milk

ACTIVE COMPARATOR

Participants will ingest 2 cups of rice milk on 1 ocassion prior to measuring postprandial vascular function

Other: Rice Milk

Interventions

Participants will ingest 2 cups of low-fat milk on 1 occasion.

Low-Fat Dairy

Participants will ingest 2 cups of rice milk on 1 occasion.

Rice Milk

Eligibility Criteria

Age18 Years - 50 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • specific criteria of the metabolic syndrome (waist circumference (102-137 or 88-123 cm for men and women, respectively), fasting triglycerides 150-300 mg/dL, and fasting glucose (110-180 mg/dL)
  • BMI: \>30 kg/m2,
  • non-dietary supplement users for \>2-mo
  • no use of any prescription or over-the-counter medications known to affect vasodilatory responses
  • no known history of vascular disease
  • nonsmokers
  • resting blood pressure \<140 mmHg
  • not taking any medications that control hypertension

You may not qualify if:

  • lactose-intolerant
  • excessive alcohol consumption (\>3 drinks/d or \>10 drinks/wk)
  • \>7 h/wk of aerobic activity
  • use of medications known to affect carbohydrate or lipid/lipoprotein metabolism
  • regular use of any anti-inflammatory medications (e.g. aspirin, non-steroidal anti-inflammatory drugs) or over-the-counter aids (e.g. fish oils)
  • women who are pregnant, lactating, and have initiated or changed birth control in the past 3-mo

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Connecticut

Storrs, Connecticut, 06269, United States

Location

Related Publications (1)

  • Ballard KD, Mah E, Guo Y, Pei R, Volek JS, Bruno RS. Low-fat milk ingestion prevents postprandial hyperglycemia-mediated impairments in vascular endothelial function in obese individuals with metabolic syndrome. J Nutr. 2013 Oct;143(10):1602-10. doi: 10.3945/jn.113.179465. Epub 2013 Aug 21.

MeSH Terms

Conditions

Cardiovascular DiseasesMetabolic SyndromeObesity

Interventions

Diet, Fat-Restricted

Condition Hierarchy (Ancestors)

Insulin ResistanceHyperinsulinismGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesOverweightOvernutritionNutrition DisordersBody WeightSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Diet TherapyNutrition TherapyTherapeuticsDietNutritional Physiological PhenomenaDiet, Food, and NutritionPhysiological Phenomena

Study Officials

  • Richard S Bruno, PhD, RD

    University of Connecticut

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
BASIC SCIENCE
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

August 4, 2011

First Posted

August 8, 2011

Study Start

August 1, 2011

Primary Completion

August 1, 2012

Study Completion

October 1, 2013

Last Updated

January 6, 2014

Record last verified: 2014-01

Locations